Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CYSTOP-OD
- Development stage
- Unknown
- Lead developer
- MMC Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CYSTOP-OD is an oral combination nutraceutical formulation developed and marketed by MMC Healthcare (MMC Pharmaceuticals Ltd) for the management of Polycystic Ovary Syndrome (PCOS). The product contains a synergistic 40:1 ratio of myo-inositol (4.0g) and D-chiro-inositol (100mg), which act as second messengers in the insulin signaling pathway to improve insulin sensitivity and restore ovulatory function. Additionally, the formulation includes melatonin (3.0mg) to enhance oocyte quality and protect against oxidative stress, L-methylfolate calcium (200mcg) to support healthy folate levels, and Vitamin D3 (400 IU) to address common metabolic and reproductive deficiencies associated with PCOS. It is typically administered as sugar-free granules in 7g sachets and is marketed in India.
- Brand names
- CYSTOP-OD
02
Targets
MTNR1A (MT1)INSR (Insulin receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on CYSTOP-OD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CYSTOP-OD.